Full history for every metric is available with a Kvantra account

Stock profile

NovaBay Pharmaceuticals, Inc. (NBY)

Country: United States of AmericaSector: HealthcareIndustry: BiotechnologyExchange: AMEX

Delisted · last close 18 Jun 2026

Current price
1.22 USD+2.52%
Last close 18 Jun 2026
Benchmarks

Key financial summary

Financials in USD
202020212022202320242025TTM
Total revenue$m101014101002
Operating profit$m-8-
Net profit$m-11-6-11-10-7-22-
EPS reported$-3.80-
Operating cashflow per share$-1.45-0.38
Capex per share$0.002.48
FCF per share$-1.452.10
Free cash flow$m-865
Net debt$m-8-7
Book value equity$m-23-
Book value per share$-3.92-
Number of sharesm5.8231.05
DPS (TTM paid)$4.004.00

Financial summary

Financials in USD
202020212022202320242025TTM
Value
P/E TTMx--
P/B LTMx-7.190.36
P/S LTMx0.0015.89
P/FCF LTMx-19.470.60
EV/EBITDA LTMx-21.08-0.74
EV/Sales LTMx0.0013.06
Earnings Yield LTM%-13.49%1059.3%
FCF Yield%-5.14%166.28%
Quality
ROE%97.00%789.69%
ROIC%-90.49%-34.47%
Operating margin%0.00%-1780.7%
Gross margin%0.00%0.00%
FCF/Sales%-2642.1%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%-100.00%-48.15%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%2.93%272.13%
Dividend Growth%--
Payout Ratio%-21.78%-7.72%
FCF/Debtx-10.86-
Net Debt/EBITDAx0.960.16
EBIT/Net interestx-27.38843.44
Net debt/market cap%-4.81%-17.80%
Net debt/Equityx0.35-
Gross debt/equityx-0.03-

Company overview

NovaBay Pharmaceuticals, Inc. (NBY) is a pharmaceutical company that specializes in developing and globally distributing products for eyecare and dermatology. Its product portfolio includes Avenova, an advanced solution designed for cleaning the delicate skin around the eye, such as the eyelids, by removing foreign substances, microorganisms, and debris. The company also offers wound management solutions under its NeutroPhase and PhaseOne brands. Furthermore, NovaBay provides a variety of dermatological treatments through its DERMAdoctor brand, addressing diverse skin concerns. These include conditions like keratosis pilaris, rosacea, and eczema, as well as anti-aging formulations, SPF protection, remedies for hyperhidrosis (excessive sweating), solutions for unwanted hair, and acne treatments. The company distributes its products through a multi-channel approach, utilizing traditional retailers, digital beauty platforms, various distributors, and its own online sales channels. Founded in 2000, the company was initially known as NovaCal Pharmaceuticals, Inc., before officially adopting the name NovaBay Pharmaceuticals, Inc. in February 2007. Its corporate headquarters are located in Emeryville, California.

WebsiteN/A
IndustryBiotechnology
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 18 Jun 2026

NovaBay Pharmaceuticals, Inc. (NBY)

NBY · AMEX · Healthcare
1.22 USD+2.52%
Benchmarks
Financialsin USD
20242025TTM
About

NovaBay Pharmaceuticals, Inc. (NBY) is a pharmaceutical company that specializes in developing and globally distributing products for eyecare and dermatology. Its product portfolio includes Avenova, an advanced solution designed for cleaning the delicate skin around the eye, such as the eyelids, by removing foreign substances, microorganisms, and debris. The company also offers wound management solutions under its NeutroPhase and PhaseOne brands. Furthermore, NovaBay provides a variety of dermatological treatments through its DERMAdoctor brand, addressing diverse skin concerns. These include conditions like keratosis pilaris, rosacea, and eczema, as well as anti-aging formulations, SPF protection, remedies for hyperhidrosis (excessive sweating), solutions for unwanted hair, and acne treatments. The company distributes its products through a multi-channel approach, utilizing traditional retailers, digital beauty platforms, various distributors, and its own online sales channels. Founded in 2000, the company was initially known as NovaCal Pharmaceuticals, Inc., before officially adopting the name NovaBay Pharmaceuticals, Inc. in February 2007. Its corporate headquarters are located in Emeryville, California.

IndustryBiotechnology
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free